intuit surgic recent procedur growth remark
updat forecast estim
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data apr
rate updat apr
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
star align perfectli intuit surgic
compani continu gain momentum gener surgeri
hernia colorect procedur enjoy robust growth
meanwhil matur procedur dvp dvh enjoy
unexpect renaiss larg due factor unlik repeat
total procedur growth highest level sinc
total volum half intuit perform
defi expect howev caution growth
like moder even compani continu discov
pocket opportun
consid long-term thesi compani particularli
conserv even compani procedur volum
exceed million think total address market sever
time size still offer compani ampl growth opportun
particularli oversea ultim ceil robot surgeri
virtual unlimit exist applic scratch
surfac possibl procedur could migrat robot
number categori still offer sizabl unpenetr
under-penetrated opportun outsid unit
state robot surgeri accept develop
world significantli lower absenc
formid competitor intuit surgic
continu domin robot surgeri arena
believ growth start deceler number
procedur penetr rate hit ceil area
dvp also believ compani increasingli run
manual laparoscopi viabl altern particularli
high-volum procedur appendectomi need
continu suppli practition tangibl evid
benefit robot surgeri clinic well econom
front compani
reli growth
intern seen skeptic past
said believ intuit competit posit remain superb
system sale probabl never reach growth rate
past compani still healthi growth profil
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
intuit surgic develop produc market robot system
assist minim invas surgeri also provid instrument
dispos accessori warranti servic system compani
place nearli da vinci system hospit world-wide
instal unit state grow number emerg
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
rais fair valu estim materi
per share account growth procedur
project materi
expect forecast system sale instrument
servic revenu directli tie procedur volum
forecast intuit growth compound annual
growth rate driven gener surgeri matur
procedur deceler
expect adjust oper margin stay well
entir forecast impli double-digit growth
oper incom period margin
expans trajectori slower intuit
abl deliv recent believ sever factor slow
expans
futur mix toward
lower-pr procedur roll-out lower-pr platform
carri lower margin eventu pressur
gener surgeri success caught us surpris
compani strong perform colorect includ
forecast hernia came nowher
procedur surpass dvh volum
year gener surgeri largest categori
volum procedur annual
still forecast healthi expans total volum
grow doubl digit averag next decad
forecast gynecolog urolog bit
temper forese procedur repeat
unexpect volum jump deceler
 overal hysterectomi market like continu
per year chang percept toward
benign hysterectomi like caus dvh struggl
expand penetr rate beyond current level
 project benign dvh volum grow
singl digit throughout long-term forecast
overal procedur growth rate averag high singl
digit throughout forecast
expect growth rate system revenu becom
much less attract opinion vast major
instal platform easili absorb addit procedur
util rate go averag sell price
pressur forecast system sale low
singl digit instrument servic revenu expect
grow rapidli midsingl high singl digit
per year line procedur growth forecast
virtual upsid limit valuat
compani fate tie size procedur market
abl penetr marketplac million
procedur main reason firm almost
alway command lofti valuat multipl bull
case expect firm total procedur volum grow
million would boost revenu
compound-annual-growth-rate teen forecast oper margin grow
minim compani maintain price structur
face competit fair valu estim jump
per share forecast approxim near current
trade level consid scenario highli
downsid could see downward pressur dvp
acceler dvh lose share laparoscopi
procedur fail make much ground procedur compound-annual-growth-rate
stay around system revenu declin part
owe competit pressur instrument servic
revenu rise midsingl digit margin also
pressur valuat drop per share
given wide rang outcom believ high
uncertainti rate appropri
expand instal base roughli da
vinci system vast procedur databas think
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
surgeon recruit will patient howev
certain compet instrument -- price attract -- may
procedures/speci current
under-penetrated intuit particularli hospit
balk da vinci cost
cost becom exorbit averag system price
around million repres larg portion typic
would need compel technolog price differ
switch machin wear natur
upgrad cycl around five eight year given need
purchas new instrument procedur instal
system provid rel depend stream
revenu per procedur long surgeon continu use
biggest threat intuit moat futur robot
surgeri gener plausibl cash-strap
hospit receiv addit reimburs robot
usag may opt plod yet cheaper altern
manual laparoscopi particularli clinic bodi work
support robot surgeri tradit mi lack
also plausibl robot surgeri may face applic
limit consid number variou
procedur alreadi perform da vinci seem
moat trend stabl stage game intuit
surgic meaning direct competitor
extend definit competit includ manual
laparoscopi intuit abil expand competit
unchalleng robot surgeri field
increasingli run manual surgeri particularli
ventur outsid core surgic area switch
cost anoth robot high hospit custom
intuit surgic dug wide moat around busi
system instrument price reflect firm
monopoli statu nich allow
achiev profit rare enjoy medic equip
maker adjust oper margin
fact gross margin intuit system compar
instrument consum compon profit
distinct industri consum
rare attract rapidli grow market
robot surgeri stay impenetr competit
long firm monopoli sooner later
ceas exist sever emerg competitor
none potenti significantli disrupt firm
oper erod return capit intuit
intellectu properti
system grow
instrument base sizeabl barrier
ever-grow clinic databas present biggest
challeng new entrant amass bodi data
intuit possess new competitor convinc
enough hospit purchas trial instrument
extens period train robot-na da vinci-train
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
term money train surgeon switch manual
lap done significantli less effort given
surgeon familiar mi forecast
procedur overal convert robot surgeri
next decad around procedur compound-annual-growth-rate
firm profit per procedur come
sever reason fewer greenfield opportun
 marketplac fulli satur lower averag sell
price dispos platform share
special challeng procedur sell cycl
intuit research develop product may also
start declin fewer procedur opportun
emerg innov cycl -- low-hang fruit
pick compani invest heavili
order penetr variou surgic special
outsid core market final see nois
competit front threat firm
moat might make certain procedur suscept
price pressur
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oth da vinci system assist multipl type
hospit drive procedur
intuit surgic potenti specialis rival
on-going high-margin instrument sale servic
revenu provid clinic case histori
sought surgeon hospit administr
ointuit surgic direct rival grow
base user build career
profici da vinci
owe may see emerg
competit particularli lower-cost procedur
oth firm averag utilis rate well
instal challeng hospit tri
maxim exist da vinci util
orobot gynaecolog slow probabl
continu declin forese futur along
hysterectomi gener owe gener
overus procedur
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
intuit balanc sheet spotless zero debt
ampl cash compani could arguabl leverag
balanc sheet strict cash deploy polici limit
usag tuck-in acquisit reinvest share
buyback compani resum buy-back polici recent
could acceler need balanc sheet health
concern extrem limit
one key long-term risk
competitor introduc compel altern da vinci
procedur siphon intuit growth
opportun potenti reduc profit
busi particularli curiou alphabet foray
robot surgeri via joint ventur johnson
johnson littl known respect industri giant
work interest field alon worth
monitor asid competit factor could
surgeri yet establish good altern
manual laparoscopi certain procedur benign
hysterectomi well gener surgeri reimburs
distinguish manual robot mi
robot instrument cost hospit forc
eat differ two procedur
clinic benefit well establish manual laparoscopi
outsid unit state cautiou adopt
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
intuit surgic superb record come
organ growth return capit technolog
revolutionari testament intuit
vision manag team abil drive
adopt expand area
superb applaud compani dedic
shield robust return capit avers expans
unrel area via acquisit appropri
share-buyback polici appear slow
compani share
stewardship rate exemplari
repres date owner name posit common share held report holder issuer
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
firm make distribut research develop
system revenu growth robust
instal base impli uptick util
improv util partli attribut healthi
dvp dvh volum support compani
assess gynecolog surgeri increasingli perform
higher-volum
percentag total unit sale attribut trade-in
oper leas trade-in like moder
compani oper leas strategi pay
leas account grow number
placement could valuabl macro condit
weaken still view tremend opportun new
system particularli outsid total instal
next decad
anticip moder jan
intuit surgic procedur growth fourth quarter
larg align previou quarter robust trend
procedur growth quarter result
moder still strong uptak procedur
forecast procedur
like increas forecast like
lower end firm growth rang
guidanc intend slightli rais fair valu estim
roll model incorpor higher number
anticip share still trade materi
valuat despit pend entranc
sever new player robot surgeri maintain
wide moat rate intuit
procedur growth driven
outsid grew line histor
number even assum compani penetr
sizabl percentag target market forecast nearli
million davinci procedur
estim million-procedur market compani
growth still like moder consider come
year believ gener surgeri strong
hernia colorect adopt opportun
still sizabl anticip moder even possibl
pullback matur procedur market
respons nearli firm sale
convey recent strength domest market also
notabl risk procedur growth normal system
demand deceler see opportun davinci
outsid japan particular strong
quarter bolster addit reimburs
firm margin earn growth line
expect anticip margin pressur
new sp model roll-out invest
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
